# Health In Tech, Inc.: overview

HIT · Nasdaq · CIK 2019505 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/hit.md) · [Financials](/companies/hit/financials.md) · [Filings](/companies/hit/filings.md) · [Insiders](/companies/hit/insiders.md)

Latest reported revenue: [$8.1m](/filings/0001213900-26-089157.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Aug 13, 2026 (XBRL us-gaap:Revenues, accession 0001213900-26-089157).

## Last eight quarters

| Line item | Unit | period not labelled (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $k | [4,459](/filings/0001213900-25-109379.md) | [4,905 d](/filings/0001213900-26-034211.md) | [8,015](/filings/0001213900-26-056707.md) | [9,314](/filings/0001213900-26-089157.md) | [8,490](/filings/0001213900-25-109379.md) | [7,509 d](/filings/0001213900-26-034211.md) | [8,772](/filings/0001213900-26-056707.md) | [8,057](/filings/0001213900-26-089157.md) |
| Gross margin | % | [78.0%](/filings/0001213900-25-109379.md) | [77.4% d](/filings/0001213900-26-034211.md) | [66.8%](/filings/0001213900-26-056707.md) | [67.7%](/filings/0001213900-26-089157.md) | [60.6%](/filings/0001213900-25-109379.md) | [55.0% d](/filings/0001213900-26-034211.md) | [51.4%](/filings/0001213900-26-056707.md) | [48.7%](/filings/0001213900-26-089157.md) |
| Operating margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Net margin | % | [8.4%](/filings/0001213900-25-109379.md) | [(2.9%) d](/filings/0001213900-26-034211.md) | [6.2%](/filings/0001213900-26-056707.md) | [6.8%](/filings/0001213900-26-089157.md) | [5.3%](/filings/0001213900-25-109379.md) | [(4.0%) d](/filings/0001213900-26-034211.md) | [(18.1%)](/filings/0001213900-26-056707.md) | [(31.2%)](/filings/0001213900-26-089157.md) |
| Diluted EPS | $ per share | [0.01](/filings/0001213900-25-109379.md) | not reported | [0.01](/filings/0001213900-26-056707.md) | [0.01](/filings/0001213900-26-089157.md) | [0.01](/filings/0001213900-25-109379.md) | not reported | [(0.03)](/filings/0001213900-26-056707.md) | [(0.04)](/filings/0001213900-26-089157.md) |
| Free cash flow | $k | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Revenue. XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure.

## Last five fiscal years

| Line item | Unit | FY (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: |
| Revenue | $m | [19.2](/filings/0001213900-25-024561.md) | [19.5](/filings/0001213900-26-034211.md) | [33.3](/filings/0001213900-26-034211.md) |
| Gross margin | % | [88.0%](/filings/0001213900-25-024561.md) | [79.2%](/filings/0001213900-26-034211.md) | [62.8%](/filings/0001213900-26-034211.md) |
| Operating margin | % | not reported | not reported | not reported |
| Net margin | % | [20.7%](/filings/0001213900-25-024561.md) | [3.4%](/filings/0001213900-26-034211.md) | [3.8%](/filings/0001213900-26-034211.md) |
| Diluted EPS | $ per share | not reported | [0.01](/filings/0001213900-26-034211.md) | [0.02](/filings/0001213900-26-034211.md) |
| Free cash flow | $m | not reported | not reported | not reported |

- Revenue. XBRL Revenue: us-gaap:Revenues.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:Revenues.
- Operating margin (operating income / revenue). XBRL Revenue: us-gaap:Revenues.
- Net margin (net income / revenue). XBRL Net income: us-gaap:ProfitLoss; Revenue: us-gaap:Revenues; Net income: us-gaap:NetIncomeLoss.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/hit/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [Whetstone Capital Advisors, LLC](/funds/1607278.md) | 2026-06-30 | $1.5m | 1,509,766 |  | New +1,509,766 |
| [Mink Brook Asset Management LLC](/funds/2052205.md) | 2026-06-30 | $1.1m | 1,133,369 |  | Added +326,908 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $574.2k | 568,475 |  | Added +3,000 |
| [HEIGHTS CAPITAL MANAGEMENT, INC](/funds/1081698.md) | 2026-06-30 | $353.8k | 350,268 |  | Reduced −23,030 |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $353.1k | 349,595 |  | Added +64,940 |
| [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $222.9k | 220,650 |  | Added +37,325 |
| [CITADEL ADVISORS LLC](/funds/1423053.md) | 2026-06-30 | $178.7k | 176,911 |  | Added +140,279 |
| [VANGUARD FIDUCIARY TRUST CO](/funds/933478.md) | 2026-06-30 | $131.8k | 130,482 |  | Added +55,914 |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $63.5k | 62,900 |  | Unchanged |
| [NORTHERN TRUST CORP](/funds/73124.md) | 2026-06-30 | $58.2k | 57,659 |  | Added +21,509 |

## Recent filings

[All 176 filings](/companies/hit/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-26 | 16:33 ET | [8-K](/filings/0001213900-26-112502.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-112502 |
| 2026-10-16 | 16:30 ET | [8-K](/filings/0001213900-26-110269.md) | 3.01 Delisting notice | 0001213900-26-110269 |
| 2026-10-13 | 08:00 ET | [DEF 14A](/filings/0001213900-26-108738.md) | Proxy statement, period 2026-11-10 | 0001213900-26-108738 |
| 2026-09-30 | 16:35 ET | [8-K](/filings/0001213900-26-105280.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-105280 |
| 2026-08-13 | 17:17 ET | [8-K](/filings/0001213900-26-089249.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-089249 |
| 2026-08-13 | 16:35 ET | [8-K](/filings/0001213900-26-089165.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-089165 |
| 2026-08-13 | 16:35 ET | [8-K](/filings/0001213900-26-089164.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-089164 |
| 2026-08-13 | 16:31 ET | [10-Q](/filings/0001213900-26-089157.md) | Quarterly report, period 2026-06-30 | 0001213900-26-089157 |
| 2026-05-14 | 16:34 ET | [10-Q](/filings/0001213900-26-056707.md) | Quarterly report, period 2026-03-31 | 0001213900-26-056707 |
| 2026-05-14 | 18:15 ET | [8-K](/filings/0001213900-26-056014.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-056014 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001213900-26-034211.md), filed Mar 25, 2026.

## Forecast league

Q3 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/658b75df-48e3-4642-84b7-b33139134ce4)

## About the filer

- CIK: 2019505
- Tickers: HIT
- Exchange: Nasdaq
- SIC code: 6411 Insurance Agents, Brokers & Service
- State of incorporation: not reported
- Filer category: <br>Emerging growth company

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 29, 2026, 04:33 ET. No prices; not investment advice.